Long-term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Participants with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study

Author:Howard, James   Li, Yuebing   Vu, Tuan   Korobko, Denis   Steeland, Sophie   Van Hoorick, Benjamin   Podhorna, Jana   Hodari, Moana   Utsugisawa, Kimiaki   Sacca, Francesco   Wiendl, Heinz   De Bleecker, Jan   Mantegazza, Renato   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.008  

Author Institution:Department of Neurology, The University of North Carolina, Chapel Hill, North Carolina, Chapel Hill, NC  Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, Florida, Tampa, FL  State Budgetary Healthcare Institution of Novosibirsk Region "State Novosibirsk Regional Clinical Hospital," Novosibirsk, Russia, Novosibirsk, Russian Federation  argenx, Ghent, Belgium, Ghent, Belgium  argenx, Ghent, Belgium, Ghent , Belgium  argenx, Ghent, Belgium, Wiesbaden, Germany  argenx, Ghent, Belgium, Camberley, United Kingdom  Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan, Hanamaki, Japan  NRSO Department, Federico II University of Naples, Naples, Italy, Napoli, Italy  Department of Neurology, University of Münster, Münster, Germany, Muenster, Germany  Ghent University Hospital, Ghent, Belgium , Gent, Belgium  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta, Milan, Italy, Milan, Italy  

Fixed-cycle and Continuous Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Study Design of ADAPT NXT

Author:Bril, Vera   Hussain, Yessar   Gwathmey, Kelly   Sahagian, Gregory   Habib, Ali   Claeys, Kristl   Cortes-Vicente, Elena   Brauer, Edward   Gelinas, Deborah   Sumbul, Anne   Jimenez, Rosa   Hristova, Daniela   Mantegazza, Renato   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.010  

Author Institution:Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, Toronto, Ontario, Canada  University of Toronto, Toronto, Ontario, Canada, Toronto, ON, Canada  Austin Neuromuscular Center, Austin, Texas, Austin, TX  Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, Richmond, VA  The Neurology Center of Southern California, Carlsbad, California, Carlsbad, CA  Department of Neurology, University of California, Irvine, Irvine, California, Orange County, CA  Department of Neurology, University Hospitals Leuven, Leuven, Belgium, Leuven, Belgium  Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, Barcelona, Spain  argenx, Ghent, Belgium, Boston, MA  argenx, Ghent, Belgium, Chapel Hill, NC  argenx, Ghent, Belgium, Tervuren, Belgium  argenx, Ghent, Belgium, Hampton Roads, VA  argenx, Ghent, Belgium, Greater Boston, MA  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta, Milan, Italy , Milan, Italy